Hôpital Gui de Chauliac

Running trials

• Not yet recruiting

  Evaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging

  NCT07245589· Source

• Recruiting

  PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

  NCT05387954· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

  NCT03958877· Phase 3· Source

• Recruiting

  French Registry for Monitoring Pregnancies for Multiple Sclerosis

  NCT03900221· Source

• Recruiting

  Dat'Aids Prevention

  NCT03795376· Source

• Recruiting

  Quality of Care in French HIV Infected Patients

  NCT02898987· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV2 recruiting
• Multiple sclerosis2 recruiting
• Hepatitis C1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Source

• Completed

  Study of Predictive Factors of Progression of Motor Neurone Disease

  NCT02360891· Source